 | • レポートコード：QYR2104Z3030 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、IL-6阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（IL-6受容体拮抗抗体、IL-6抗体）、用途別市場規模（自己免疫疾患治療、アジュバントがん治療、新型コロナウイルス感染症治療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・IL-6阻害剤の市場動向 ・企業の競争状況、市場シェア ・IL-6阻害剤の種類別市場規模（IL-6受容体拮抗抗体、IL-6抗体） ・IL-6阻害剤の用途別市場規模（自己免疫疾患治療、アジュバントがん治療、新型コロナウイルス感染症治療） ・IL-6阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・IL-6阻害剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・IL-6阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・IL-6阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・IL-6阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Regeneron Pharmaceuticals Inc.、Sanofi、Janssen Global Services LLC、Novimmune SA、UCB Pharma） ・結論 |
IL-6 Inhibitors, which are now considered as promising treatment for COVID-19, target the IL-6 receptors (IL-6Rs), thereby preventing the binding of IL-6 ligands to IL-6 receptors. Thus, inhibiting the entire IL-6 signal transduction . The Interleukin 6 (IL-6) family is a large and diverse group of cytokines (IL-6, IL-11, IL-27, IL-31, OSM, LIF, CNTF, CT-1 and CLCF1) that is defined based on the use of common β-receptor signaling subunits, which could induce fever in patients
Market Analysis and Insights: Global IL-6 Inhibitors Market
The global IL-6 Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IL-6 Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IL-6 Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IL-6 Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IL-6 Inhibitors market.
Global IL-6 Inhibitors Scope and Market Size
IL-6 Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IL-6 Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
IL-6 Receptors Antagonistic Anitibody
Antibody against IL-6
Segment by Application
Autoimmune Diease Treatment
Ajuvant Cancer Treatment
COVID-19 Therapy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Regeneron Pharmaceuticals Inc.
Sanofi
Janssen Global Services LLC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IL-6 Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IL-6 Receptors Antagonistic Anitibody
1.2.3 Antibody against IL-6
1.3 Market by Application
1.3.1 Global IL-6 Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune Diease Treatment
1.3.3 Ajuvant Cancer Treatment
1.3.4 COVID-19 Therapy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global IL-6 Inhibitors Market Perspective (2016-2027)
2.2 IL-6 Inhibitors Growth Trends by Regions
2.2.1 IL-6 Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 IL-6 Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 IL-6 Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 IL-6 Inhibitors Industry Dynamic
2.3.1 IL-6 Inhibitors Market Trends
2.3.2 IL-6 Inhibitors Market Drivers
2.3.3 IL-6 Inhibitors Market Challenges
2.3.4 IL-6 Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IL-6 Inhibitors Players by Revenue
3.1.1 Global Top IL-6 Inhibitors Players by Revenue (2016-2021)
3.1.2 Global IL-6 Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global IL-6 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IL-6 Inhibitors Revenue
3.4 Global IL-6 Inhibitors Market Concentration Ratio
3.4.1 Global IL-6 Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IL-6 Inhibitors Revenue in 2020
3.5 IL-6 Inhibitors Key Players Head office and Area Served
3.6 Key Players IL-6 Inhibitors Product Solution and Service
3.7 Date of Enter into IL-6 Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IL-6 Inhibitors Breakdown Data by Type
4.1 Global IL-6 Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global IL-6 Inhibitors Forecasted Market Size by Type (2022-2027)
5 IL-6 Inhibitors Breakdown Data by Application
5.1 Global IL-6 Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global IL-6 Inhibitors Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America IL-6 Inhibitors Market Size (2016-2027)
6.2 North America IL-6 Inhibitors Market Size by Type
6.2.1 North America IL-6 Inhibitors Market Size by Type (2016-2021)
6.2.2 North America IL-6 Inhibitors Market Size by Type (2022-2027)
6.2.3 North America IL-6 Inhibitors Market Size by Type (2016-2027)
6.3 North America IL-6 Inhibitors Market Size by Application
6.3.1 North America IL-6 Inhibitors Market Size by Application (2016-2021)
6.3.2 North America IL-6 Inhibitors Market Size by Application (2022-2027)
6.3.3 North America IL-6 Inhibitors Market Size by Application (2016-2027)
6.4 North America IL-6 Inhibitors Market Size by Country
6.4.1 North America IL-6 Inhibitors Market Size by Country (2016-2021)
6.4.2 North America IL-6 Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe IL-6 Inhibitors Market Size (2016-2027)
7.2 Europe IL-6 Inhibitors Market Size by Type
7.2.1 Europe IL-6 Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe IL-6 Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe IL-6 Inhibitors Market Size by Type (2016-2027)
7.3 Europe IL-6 Inhibitors Market Size by Application
7.3.1 Europe IL-6 Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe IL-6 Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe IL-6 Inhibitors Market Size by Application (2016-2027)
7.4 Europe IL-6 Inhibitors Market Size by Country
7.4.1 Europe IL-6 Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe IL-6 Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific IL-6 Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific IL-6 Inhibitors Market Size by Type
8.2.1 Asia-Pacific IL-6 Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific IL-6 Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific IL-6 Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific IL-6 Inhibitors Market Size by Application
8.3.1 Asia-Pacific IL-6 Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific IL-6 Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific IL-6 Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific IL-6 Inhibitors Market Size by Region
8.4.1 Asia-Pacific IL-6 Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific IL-6 Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America IL-6 Inhibitors Market Size (2016-2027)
9.2 Latin America IL-6 Inhibitors Market Size by Type
9.2.1 Latin America IL-6 Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America IL-6 Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America IL-6 Inhibitors Market Size by Type (2016-2027)
9.3 Latin America IL-6 Inhibitors Market Size by Application
9.3.1 Latin America IL-6 Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America IL-6 Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America IL-6 Inhibitors Market Size by Application (2016-2027)
9.4 Latin America IL-6 Inhibitors Market Size by Country
9.4.1 Latin America IL-6 Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America IL-6 Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IL-6 Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa IL-6 Inhibitors Market Size by Type
10.2.1 Middle East & Africa IL-6 Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa IL-6 Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa IL-6 Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa IL-6 Inhibitors Market Size by Application
10.3.1 Middle East & Africa IL-6 Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa IL-6 Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa IL-6 Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa IL-6 Inhibitors Market Size by Country
10.4.1 Middle East & Africa IL-6 Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa IL-6 Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche IL-6 Inhibitors Introduction
11.1.4 Roche Revenue in IL-6 Inhibitors Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Regeneron Pharmaceuticals Inc.
11.2.1 Regeneron Pharmaceuticals Inc. Company Details
11.2.2 Regeneron Pharmaceuticals Inc. Business Overview
11.2.3 Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Introduction
11.2.4 Regeneron Pharmaceuticals Inc. Revenue in IL-6 Inhibitors Business (2016-2021)
11.2.5 Regeneron Pharmaceuticals Inc. Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi IL-6 Inhibitors Introduction
11.3.4 Sanofi Revenue in IL-6 Inhibitors Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Janssen Global Services LLC
11.4.1 Janssen Global Services LLC Company Details
11.4.2 Janssen Global Services LLC Business Overview
11.4.3 Janssen Global Services LLC IL-6 Inhibitors Introduction
11.4.4 Janssen Global Services LLC Revenue in IL-6 Inhibitors Business (2016-2021)
11.4.5 Janssen Global Services LLC Recent Development
11.5 Novimmune SA
11.5.1 Novimmune SA Company Details
11.5.2 Novimmune SA Business Overview
11.5.3 Novimmune SA IL-6 Inhibitors Introduction
11.5.4 Novimmune SA Revenue in IL-6 Inhibitors Business (2016-2021)
11.5.5 Novimmune SA Recent Development
11.6 UCB Pharma
11.6.1 UCB Pharma Company Details
11.6.2 UCB Pharma Business Overview
11.6.3 UCB Pharma IL-6 Inhibitors Introduction
11.6.4 UCB Pharma Revenue in IL-6 Inhibitors Business (2016-2021)
11.6.5 UCB Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global IL-6 Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of IL-6 Receptors Antagonistic Anitibody
Table 3. Key Players of Antibody against IL-6
Table 4. Global IL-6 Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global IL-6 Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global IL-6 Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global IL-6 Inhibitors Market Share by Regions (2016-2021)
Table 8. Global IL-6 Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global IL-6 Inhibitors Market Share by Regions (2022-2027)
Table 10. IL-6 Inhibitors Market Trends
Table 11. IL-6 Inhibitors Market Drivers
Table 12. IL-6 Inhibitors Market Challenges
Table 13. IL-6 Inhibitors Market Restraints
Table 14. Global IL-6 Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global IL-6 Inhibitors Market Share by Players (2016-2021)
Table 16. Global Top IL-6 Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IL-6 Inhibitors as of 2020)
Table 17. Ranking of Global Top IL-6 Inhibitors Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by IL-6 Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players IL-6 Inhibitors Product Solution and Service
Table 21. Date of Enter into IL-6 Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IL-6 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 24. Global IL-6 Inhibitors Revenue Market Share by Type (2016-2021)
Table 25. Global IL-6 Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global IL-6 Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global IL-6 Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global IL-6 Inhibitors Revenue Market Share by Application (2016-2021)
Table 29. Global IL-6 Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global IL-6 Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America IL-6 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 32. North America IL-6 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America IL-6 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 34. North America IL-6 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America IL-6 Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America IL-6 Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe IL-6 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe IL-6 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe IL-6 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe IL-6 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe IL-6 Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe IL-6 Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific IL-6 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific IL-6 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific IL-6 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific IL-6 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific IL-6 Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific IL-6 Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America IL-6 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America IL-6 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America IL-6 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America IL-6 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America IL-6 Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America IL-6 Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa IL-6 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa IL-6 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa IL-6 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa IL-6 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa IL-6 Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa IL-6 Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche IL-6 Inhibitors Product
Table 64. Roche Revenue in IL-6 Inhibitors Business (2016-2021) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Regeneron Pharmaceuticals Inc. Company Details
Table 67. Regeneron Pharmaceuticals Inc. Business Overview
Table 68. Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Product
Table 69. Regeneron Pharmaceuticals Inc. Revenue in IL-6 Inhibitors Business (2016-2021) & (US$ Million)
Table 70. Regeneron Pharmaceuticals Inc. Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi IL-6 Inhibitors Product
Table 74. Sanofi Revenue in IL-6 Inhibitors Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Janssen Global Services LLC Company Details
Table 77. Janssen Global Services LLC Business Overview
Table 78. Janssen Global Services LLC IL-6 Inhibitors Product
Table 79. Janssen Global Services LLC Revenue in IL-6 Inhibitors Business (2016-2021) & (US$ Million)
Table 80. Janssen Global Services LLC Recent Development
Table 81. Novimmune SA Company Details
Table 82. Novimmune SA Business Overview
Table 83. Novimmune SA IL-6 Inhibitors Product
Table 84. Novimmune SA Revenue in IL-6 Inhibitors Business (2016-2021) & (US$ Million)
Table 85. Novimmune SA Recent Development
Table 86. UCB Pharma Company Details
Table 87. UCB Pharma Business Overview
Table 88. UCB Pharma IL-6 Inhibitors Product
Table 89. UCB Pharma Revenue in IL-6 Inhibitors Business (2016-2021) & (US$ Million)
Table 90. UCB Pharma Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IL-6 Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. IL-6 Receptors Antagonistic Anitibody Features
Figure 3. Antibody against IL-6 Features
Figure 4. Global IL-6 Inhibitors Market Share by Application: 2020 VS 2027
Figure 5. Autoimmune Diease Treatment Case Studies
Figure 6. Ajuvant Cancer Treatment Case Studies
Figure 7. COVID-19 Therapy Case Studies
Figure 8. IL-6 Inhibitors Report Years Considered
Figure 9. Global IL-6 Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global IL-6 Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global IL-6 Inhibitors Market Share by Regions: 2020 VS 2027
Figure 12. Global IL-6 Inhibitors Market Share by Regions (2022-2027)
Figure 13. Global IL-6 Inhibitors Market Share by Players in 2020
Figure 14. Global Top IL-6 Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IL-6 Inhibitors as of 2020
Figure 15. The Top 10 and 5 Players Market Share by IL-6 Inhibitors Revenue in 2020
Figure 16. Global IL-6 Inhibitors Revenue Market Share by Type (2016-2021)
Figure 17. Global IL-6 Inhibitors Revenue Market Share by Type (2022-2027)
Figure 18. North America IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America IL-6 Inhibitors Market Share by Type (2016-2027)
Figure 20. North America IL-6 Inhibitors Market Share by Application (2016-2027)
Figure 21. North America IL-6 Inhibitors Market Share by Country (2016-2027)
Figure 22. United States IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe IL-6 Inhibitors Market Share by Type (2016-2027)
Figure 26. Europe IL-6 Inhibitors Market Share by Application (2016-2027)
Figure 27. Europe IL-6 Inhibitors Market Share by Country (2016-2027)
Figure 28. Germany IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific IL-6 Inhibitors Market Share by Type (2016-2027)
Figure 36. Asia-Pacific IL-6 Inhibitors Market Share by Application (2016-2027)
Figure 37. Asia-Pacific IL-6 Inhibitors Market Share by Region (2016-2027)
Figure 38. China IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America IL-6 Inhibitors Market Share by Type (2016-2027)
Figure 46. Latin America IL-6 Inhibitors Market Share by Application (2016-2027)
Figure 47. Latin America IL-6 Inhibitors Market Share by Country (2016-2027)
Figure 48. Mexico IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa IL-6 Inhibitors Market Share by Type (2016-2027)
Figure 52. Middle East & Africa IL-6 Inhibitors Market Share by Application (2016-2027)
Figure 53. Middle East & Africa IL-6 Inhibitors Market Share by Country (2016-2027)
Figure 54. Turkey IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE IL-6 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Roche Revenue Growth Rate in IL-6 Inhibitors Business (2016-2021)
Figure 58. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in IL-6 Inhibitors Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in IL-6 Inhibitors Business (2016-2021)
Figure 60. Janssen Global Services LLC Revenue Growth Rate in IL-6 Inhibitors Business (2016-2021)
Figure 61. Novimmune SA Revenue Growth Rate in IL-6 Inhibitors Business (2016-2021)
Figure 62. UCB Pharma Revenue Growth Rate in IL-6 Inhibitors Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed